PK/PD and antiviral activity of anti-HCV therapy: is there still a role in the choice of treatment?
Author:
Affiliation:
1. Department of Infectious Diseases, IRCCS Fondazione Policlinico San Matteo, PV
2. Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1721459
Reference21 articles.
1. Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
2. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
3. Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use
4. Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
5. Resistance testing: Interpretation and incorporation into HCV treatment algorithms
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of Bacterial Key Genes from 16S rRNA-Seq Profiles That Are Associated with the Complications of SARS-CoV-2 Infections and Provide Therapeutic Indications;Pharmaceuticals;2024-03-28
2. Rapid and validated UHPLC method for simultaneous determination of sofosbuvir, ledipasvir and paracetamol as commonly repurposed drugs for COVID-19 treatment: application in spiked human plasma;Future Journal of Pharmaceutical Sciences;2023-10-23
3. Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 treatment;Future Journal of Pharmaceutical Sciences;2023-08-17
4. A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine;Vaccines;2023-02-22
5. Antiviral drugs and vaccines;Medicinal Chemistry of Chemotherapeutic Agents;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3